Safely Prescribing GLP-1 Medications for Older Adults: Remote care solutions that offer protection and connection

Transforming Obesity Treatment with GLP-1s for Older Adults

A recent survey conducted by Gallup reported that perceived effectiveness of weight loss injections are relatively consistent among younger and middle-aged adults, with 70% of those aged 18 to 49 and 67% of those aged 50 to 64 reporting them as effective or extremely effective. Among adults aged 65 and older, however, reported effectiveness is much lower, at 48%.

Older adults often face more health issues or comorbidities, which can make it challenging for them to lose weight and adhere consistently to their treatment plans. Additionally, healthcare providers may encounter greater difficulties in keeping older adults engaged and motivated throughout their weight loss journey.

This age-related disparity points to the need for more tailored treatment plans, closer monitoring of the patient’s day to day health metrics, and additional research to better understand the overall effectiveness of GLP-1 medication to treat obesity in older adults

Mitigating medication risk with remote health tech

One approach to addressing these challenges is the integration of digital care solutions, which can offer greater protection for older patients. By utilizing remote monitoring technologies, healthcare providers can track vital health metrics in real-time, allowing for prompt adjustments to treatment plans as needed. These tools can also facilitate regular communication between patients and providers, ensuring that any concerns or side effects are quickly addressed, thus enhancing the overall effectiveness and safety of the treatment.

With connected health devices that collect patient-generated data on a daily basis, care teams can have more insight into health risks that older patients are more susceptible to when taking GLP-1s:

1. Sarcopenia: About a quarter of GLP-1 agonist weight loss results from the loss of muscle and bone, both of which are necessary to protect us as we get older. Although some muscle loss is a natural part of aging, it accelerates while on GLP-1s. Weakened muscles can make everyday activities difficult, and can lead to falls or other injuries. Low muscle mass is also associated with poor health outcomes — researchers found that individuals with diabetes and low muscle mass have a higher risk of mortality from cardiovascular disease.

1. Malnutrition: Although suppression of appetite is a key mechanism of GLP-1 medications, too much appetite control can be dangerous, particularly in older adults who are more prone to having reduced food intake. Studies have found diminished appetite is a common problem for older adults — both those living at home and at care facilities. Early insight into a patient’s weight and body composition can help care teams intervene earlier to promote better appetite and food intake. Low muscle mass further compounds the risk of malnutrition. A study led by the Center for Translational Research in Aging & Longevity at Texas A&M University found that current care approaches for malnutrition often don’t account for the importance of muscle mass restoration. Researchers recognized the challenge of measuring body composition in clinical practice, noting “the need to raise awareness of the importance of screening and managing ‘at risk’ patients so it becomes routine is imperative for change to occur.”

1. Gastrointestinal side effects: Severe gastrointestinal side effects from these medications can result in dehydration, which may increase the likelihood of falls. The most commonly reported side effects include gastrointestinal issues such as vomiting and nausea. When dehydration occurs, individuals are more prone to dizziness or fainting, raising the risk of falling. For older adults a fall could be the start of serious health issues and can even lead to a long-term disability. It is essential to ensure that older adults taking weight loss medications can monitor their hydration levels on a daily basis.

Daily monitoring of lean mass, water percentage and bones mass

With the Withings Body Pro 2 cellular scale, patients can weigh in each day at home and their body composition information will transmit to their care team automatically. This scale was designed for maximum ease of use, making it ideal for older patients who may not be tech savvy — there’s no technical setup required, and patients can use it even if they don’t have a cell phone or internet service.

Daily lean mass, fat mass, water percentage and bone mass metrics provide early insight into which patients are struggling with muscle loss or malnutrition. With this data teams can more quickly identify problems and reach out to those in need. For instance, encouraging patients to increase protein in their diet, drink more water, and do light strength training may help stave off serious health issues.

Motivating and connecting

According to the Pew Research Center, about 27 percent of American seniors live alone. This puts them at higher risk of social isolation, which can affect their well-being and increase their risk of health problems. Beyond measuring body composition, the Body Pro 2 scale can deliver motivational messages to patients automatically. These messages might offer encouragement to keep walking regularly, take their readings more consistently, remind them of upcoming appointments or congratulate them for reaching a personal health goal.

Prioritizing a personalized approach

Safely prescribing GLP-1 medications for older adults requires a multifaceted approach that combines the integration of connected health devices, closer monitoring of patient body composition, and consistent patient motivation.

These technologies not only enhance the safety and effectiveness of weight loss treatments but also provide motivational support to help older patients stay engaged and connected. By addressing the unique challenges faced by older adults, healthcare providers improve the success of their program.

Disclaimer: The information provided in this article is informational and for content marketing purposes only. It should not be construed as medical advice. The content herein is not intended to replace professional medical consultation, diagnosis, or treatment. We expressly recommend that individuals seek advice from a qualified healthcare professional before considering the use of GLP-1 medications for the treatment of obesity or any other condition.